Skip to main content

Table 2 Number of cases scoring differently by at least one score from baseline to the end of treatment phase 1 (T1)

From: Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy

Age group

Affected cases

Alteration in the score at least by 1 score [n (%)]

Worse

No change

Better

Up to 2 yr

12

0 (0)

0 (0)

12 (100)

2 to 4 yr

14

0 (0)

1 (7.1)

13 (92.9)

4 to 6 yr

21

0 (0)

2 (9.5)

19 (90.5)

6 to 12 yr

27

0 (0)

2 (7.4)

25 (92.6)

12 to 18 yr

17

0 (0)

0 (0)

17 (100)